Lung cancer screening

Panacea or pipe dream?

Apar Kishor P Ganti, J. L. Mulshine

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The role of screening in lung cancer is as controversial today as it was in the 1980s. Large randomized controlled trials have conclusively demonstrated that chest X-rays and sputum cytology are too insensitive to make any impact on lung cancer-related mortality. Despite the impressive results of the studies using low-dose CT scan to screen for early lung cancer, there is no consensus regarding its application to the general population. The role of newer modalities like PET is yet to be elucidated. Further research to realize the potential of these powerful imaging modalities in routine public health application is necessary to efficiently, safely and reliably identify and manage early lung cancer.

Original languageEnglish (US)
JournalAnnals of Oncology
Volume16
Issue numberSUPPL. 2
DOIs
StatePublished - Jul 13 2005

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Sputum
Cell Biology
Thorax
Randomized Controlled Trials
Public Health
X-Rays
Mortality
Research
Population

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Lung cancer screening : Panacea or pipe dream? / Ganti, Apar Kishor P; Mulshine, J. L.

In: Annals of Oncology, Vol. 16, No. SUPPL. 2, 13.07.2005.

Research output: Contribution to journalArticle

Ganti, Apar Kishor P ; Mulshine, J. L. / Lung cancer screening : Panacea or pipe dream?. In: Annals of Oncology. 2005 ; Vol. 16, No. SUPPL. 2.
@article{94f59e3cb4f9420d800018bc0ec8f8ac,
title = "Lung cancer screening: Panacea or pipe dream?",
abstract = "The role of screening in lung cancer is as controversial today as it was in the 1980s. Large randomized controlled trials have conclusively demonstrated that chest X-rays and sputum cytology are too insensitive to make any impact on lung cancer-related mortality. Despite the impressive results of the studies using low-dose CT scan to screen for early lung cancer, there is no consensus regarding its application to the general population. The role of newer modalities like PET is yet to be elucidated. Further research to realize the potential of these powerful imaging modalities in routine public health application is necessary to efficiently, safely and reliably identify and manage early lung cancer.",
author = "Ganti, {Apar Kishor P} and Mulshine, {J. L.}",
year = "2005",
month = "7",
day = "13",
doi = "10.1093/annonc/mdi723",
language = "English (US)",
volume = "16",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Lung cancer screening

T2 - Panacea or pipe dream?

AU - Ganti, Apar Kishor P

AU - Mulshine, J. L.

PY - 2005/7/13

Y1 - 2005/7/13

N2 - The role of screening in lung cancer is as controversial today as it was in the 1980s. Large randomized controlled trials have conclusively demonstrated that chest X-rays and sputum cytology are too insensitive to make any impact on lung cancer-related mortality. Despite the impressive results of the studies using low-dose CT scan to screen for early lung cancer, there is no consensus regarding its application to the general population. The role of newer modalities like PET is yet to be elucidated. Further research to realize the potential of these powerful imaging modalities in routine public health application is necessary to efficiently, safely and reliably identify and manage early lung cancer.

AB - The role of screening in lung cancer is as controversial today as it was in the 1980s. Large randomized controlled trials have conclusively demonstrated that chest X-rays and sputum cytology are too insensitive to make any impact on lung cancer-related mortality. Despite the impressive results of the studies using low-dose CT scan to screen for early lung cancer, there is no consensus regarding its application to the general population. The role of newer modalities like PET is yet to be elucidated. Further research to realize the potential of these powerful imaging modalities in routine public health application is necessary to efficiently, safely and reliably identify and manage early lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=21344433058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344433058&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdi723

DO - 10.1093/annonc/mdi723

M3 - Article

VL - 16

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 2

ER -